| Trial Identifier: | D5495C00001 |
| Sponsor: | AstraZeneca |
| Collaborator: | Contract Research Organization: USA PAREXEL Early Phase Clinical Unit Baltimore PAREXEL Early Phase Clinical Unit-Los Angeles Clinical Laboratory: USA Harbor Hospital Laboratory GenX Laboratories Inc. Analytical Laboratory (Pharmacokinetic Sample Analysis): USA Covance Bioanalytical Services, LLC |
| NCTID: | NCT03316131 |
| Start Date: | October 2017 |
| Primary Completion Date: | July 2018 |
| Study Completion Date: | July 2018 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation |
| Country | Location |
|---|---|
| United States of America, MD | Baltimore, MD, United States of America, 21225 |
| United States of America, CA | Glendale, CA, United States of America, 91206 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company